Wendy future of retail top

Ludwig Hantson

Shire to acquire Baxalta in $32 billion deal

Shire to acquire Baxalta in $32 billion deal

DUBLIN, Ireland, and BANNOCKBURN, Ill. — Shire plc plans to buy Baxalta Inc., a biopharmaceutical company focused on orphan diseases and underserved conditions, in a cash and stock deal valued at $32 billion. Under the agreement, Baxalta shareholders will receive $18 in cash and 0.1482 Shire American depositary shares per Baxalta share, for a combined of

PP_1170x120_10-25-21